Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $956.81 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $248.86 | 17 | $0 (2024) |
| Novo Nordisk Inc | $141.09 | 8 | $0 (2024) |
| PFIZER INC. | $115.14 | 6 | $0 (2024) |
| Lilly USA, LLC | $90.57 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $67.82 | 4 | $0 (2024) |
| SANOFI PASTEUR INC. | $57.29 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $56.30 | 4 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $38.76 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $34.88 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.37 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $261.62 | 14 | ABBVIE INC. ($73.67) |
| 2023 | $602.43 | 38 | AbbVie Inc. ($145.54) |
| 2022 | $92.76 | 6 | ABBVIE INC. ($29.65) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Biological | ||||||
| 07/02/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Biological | ||||||
| 06/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: PAIN | ||||||
| 04/09/2024 | SANOFI PASTEUR INC. | VAXELIS (Biological), BEYFORTUS | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Vaccines | ||||||
| 04/08/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Diabetes | ||||||
| 03/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: PAIN | ||||||
| 12/13/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/07/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.82 | General |
| 11/08/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Biological | ||||||
| 10/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/19/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Diabetes | ||||||
| 09/27/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.82 | General |
| 09/12/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Biological | ||||||
| 09/08/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: PAIN | ||||||
| 08/23/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 44 | 76 | $23,420 | $5,649 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 35 | $8,645 | $2,070 | 23.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 21 | $7,455 | $1,869 | 25.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 20 | $7,320 | $1,711 | 23.4% |
About Dr. David Casillas Plazola, MD
Dr. David Casillas Plazola, MD is a Family Medicine healthcare provider based in Lancaster, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2019. The National Provider Identifier (NPI) number assigned to this provider is 1598228314.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Casillas Plazola, MD has received a total of $956.81 in payments from pharmaceutical and medical device companies, with $261.62 received in 2024. These payments were reported across 58 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($956.81).
As a Medicare-enrolled provider, Casillas Plazola has provided services to 44 Medicare beneficiaries, totaling 76 services with total Medicare billing of $5,649. Data is available for 1 year (2023–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lancaster, WI
- Active Since 04/09/2019
- Last Updated 06/30/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1598228314
Products in Payments
- VRAYLAR (Drug) $143.45
- NURTEC ODT (Drug) $82.76
- Veozah (Drug) $67.82
- Rybelsus (Drug) $58.06
- XARELTO (Drug) $56.30
- COMIRNATY (Biological) $52.91
- MOUNJARO (Drug) $49.53
- DALVANCE (Drug) $41.12
- EMGALITY (Drug) $41.04
- GVOKE HYPOPEN (Drug) $38.76
- MENQUADFI (Biological) $33.44
- JARDIANCE (Drug) $30.37
- VAXELIS (Biological) $23.85
- Dexcom G6 Transmitter (Medical Supply) $21.99
- ROTATEQ (Biological) $20.81
- QUTENZA (Drug) $20.28
- UBRELVY (Drug) $20.09
- LINZESS (Drug) $19.88
- Ozempic (Drug) $18.61
- Saxenda (Drug) $17.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lancaster
Dr. Stephen Gold, D.o, D.O
Family Medicine — Payments: $78,584
Dr. Michael Steelman, D.o, D.O
Family Medicine — Payments: $58,078
Dr. Stephen Diamantoni, M.d, M.D
Family Medicine — Payments: $23,670
Ruben Hernandez, Md, MD
Family Medicine — Payments: $19,567
Ryan Dammerman, Md, MD
Family Medicine — Payments: $11,706
Troy Hampton, D.o, D.O
Family Medicine — Payments: $10,969